OKYO OKYO Pharma Ltd
Price Chart
Executive Summary
Bernard Denoyer filed a Form 3 initial statement of beneficial ownership with OKYO Pharma Ltd, disclosing options to acquire 27,505 common shares at exercise prices between $1.46 and $2.13, with expiration dates through 2035. This is a routine insider filing with no market-moving information.
Actionable Insight
This is a routine initial ownership filing with no trading activity or material new information. No action warranted.
Key Facts
- Bernard Denoyer filed Form 3 as a new reporting owner of OKYO Pharma Ltd
- Denoyer holds options to purchase 27,505 common shares at exercise prices of $1.46, $1.50, $1.60, and $2.13
- Options vest in tranches from 2024 through 2029 and expire between 2033 and 2035
- No direct ownership of common stock is reported — only derivative securities
Financial Impact
No financial impact — options represent standard director/executive compensation with no immediate market effect
Risk Factors
- No material risks identified from this filing
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001493152-26-026927 |
| Document: 0001493152-26-026927-index.html | 0001493152-26-026927 |
| Document: 0001493152-26-026927.txt | 0001493152-26-026927 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
3
| $1.66 $1.68 | ▲ +1.20% | ▲ +0.81% | $1.52 (−8.43%) |
|
Jun 1, 2026
13d ago
|
3
| $1.70 $1.66 | ▼ −2.35% | ▼ −1.63% | $1.52 (−10.59%) |
|
Jun 1, 2026
13d ago
|
3
| $1.70 $1.66 | ▼ −2.35% | ▼ −1.63% | $1.52 (−10.59%) |
|
May 19, 2026
26d ago
|
6-K
| $1.60 $1.60 | · 0.00% | ▼ −1.04% | $1.52 (−5.00%) |
|
Apr 7, 2026
9w ago
|
6-K
| $1.60 $1.59 | ▼ −0.63% | ▼ −3.16% | $1.52 (−5.00%) |
|
Apr 7, 2026
9w ago
|
Press Release
| $1.60 $1.59 | ▼ −0.63% | ▼ −3.16% | $1.52 (−5.00%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $1.62 $1.57 | ▼ −3.09% | ▼ −1.34% | $1.52 (−6.17%) |
|
Mar 19, 2026
12w ago
|
Press Release
| $1.62 $1.57 | ▼ −3.09% | ▼ −1.34% | $1.52 (−6.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access